Novartis added that its formulation will ensure a low cost of goods – although whether this will translate into a low price seems unlikely as the company said it plans to “maximise its long-term value”. After completing a pharmacokinetic study with the final manufacturing process, Novartis exp...
1. What is the main topic of the passage about Eylea?A. Its side effects B. Its uses in treating certain eye diseases C. Its discovery process D. Its price in the market Answer: B 解析：文章主要围绕Eylea在治疗特定眼部疾病方面展开，介绍其用途，所以选B。2. According to the passage, ...
Eylea's net sales got a boost of about $40 million from a rise in wholesaler inventory levels for the higher-dose version at the end of the third quarter, said Regeneron. "As a result, we expect fourth-quarter Eylea HD net sales to be negatively impacted as thi...
AMUNDIadded 487,489 shares (+45.8%) to their portfolio in Q4 2024, for an estimated$347,253,039 PRICE T ROWE ASSOCIATES INC /MD/added 342,429 shares (+36.7%) to their portfolio in Q3 2024, for an estimated$359,975,061 CAPITAL WORLD INVESTORSremoved 340,280 shares (-7.3%...
As of February 22, Bayer has received 209 reports of increased IOP with the use of the prefilled syringe, out of 1.97 million prefilled syringes sold, a rate of 1.1 cases per 10,000, said Doreen Schroeder, a company spokesperson, in an email. The cases have been reported in some Europe...
(PFS) occupies 90 percent of the total sales volume, the company was the first to apply for approval from the European Medicines Agency (EMA) for an Eylea biosimilar PFS,” a company official said. “Also, our Eylea biosimilar has superior price competitiveness and does not infringe upon any...
Samsung Bioepis said SB15, a biosimilar candidate referencing Eylea (ingredient: aflibercept), demonstrated similar efficacy, safety, immunogenicity, and pharmacokinetics (PK) to the original drug in a phase 3 clinical trial. During the 2023 Annual Meeti